ICU Medical (NASDAQ:ICUI) Price Target Lowered to $191.00 at KeyCorp

ICU Medical (NASDAQ:ICUI) had its target price lowered by analysts at KeyCorp from $209.00 to $191.00 in a research note issued on Monday,Benzinga reports. The firm presently has an “overweight” rating on the medical instruments supplier’s stock. KeyCorp’s price target indicates a potential upside of 40.15% from the stock’s current price.

Other analysts also recently issued reports about the stock. StockNews.com upgraded shares of ICU Medical from a “hold” rating to a “buy” rating in a research report on Wednesday, April 16th. Raymond James set a $97.00 price target on ICU Medical in a report on Wednesday, March 12th. Finally, Needham & Company LLC reissued a “hold” rating on shares of ICU Medical in a report on Tuesday, April 8th. One research analyst has rated the stock with a hold rating, three have given a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat, ICU Medical presently has a consensus rating of “Buy” and an average target price of $162.67.

ICU Medical Stock Performance

ICUI traded down $2.39 during trading on Monday, reaching $136.29. 35,385 shares of the company were exchanged, compared to its average volume of 269,831. ICU Medical has a 52 week low of $93.36 and a 52 week high of $196.26. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75. The firm has a 50 day moving average of $146.34 and a 200 day moving average of $159.48. The stock has a market cap of $3.34 billion, a P/E ratio of -29.86 and a beta of 0.86.

Hedge Funds Weigh In On ICU Medical

Hedge funds have recently modified their holdings of the company. Norges Bank acquired a new position in shares of ICU Medical in the 4th quarter worth approximately $40,151,000. GAMMA Investing LLC lifted its position in shares of ICU Medical by 17,559.7% during the 1st quarter. GAMMA Investing LLC now owns 99,424 shares of the medical instruments supplier’s stock valued at $138,060,000 after acquiring an additional 98,861 shares during the last quarter. Point72 Asset Management L.P. grew its holdings in shares of ICU Medical by 63.2% in the 4th quarter. Point72 Asset Management L.P. now owns 245,340 shares of the medical instruments supplier’s stock worth $38,069,000 after acquiring an additional 95,030 shares during the last quarter. Dimensional Fund Advisors LP lifted its holdings in shares of ICU Medical by 18.2% during the fourth quarter. Dimensional Fund Advisors LP now owns 539,981 shares of the medical instruments supplier’s stock valued at $83,788,000 after purchasing an additional 82,982 shares during the last quarter. Finally, Raymond James Financial Inc. acquired a new stake in ICU Medical during the 4th quarter worth about $10,003,000. 96.10% of the stock is currently owned by institutional investors and hedge funds.

ICU Medical Company Profile

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.